EAM
RIGL icon

Eagle Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Eagle Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,117
Closed -$13K – 559
2022
Q3 		$13K Hold
1,117
– – ﹤0.01% 543
2022
Q2 		$12K Hold
1,117
– – ﹤0.01% 558
2022
Q1 		$33K Hold
1,117
– – ﹤0.01% 574
2021
Q4 		$29K Buy
+1,117
New +$33.7K ﹤0.01% 595
2021
Q1 		– Sell
-1,091
Closed -$38K – 661
2020
Q4 		$38K Buy
+1,091
New +$31.6K ﹤0.01% 550

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Asset Management's RIGL Position: Q4 2022 in Review

Eagle Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 1,117 shares — an estimated $13K sold.

Eagle Asset Management first reported a position in RIGL in Q4 2020 and held it in 5 quarters. The position peaked at $38K in Q4 2020. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

  • Eagle Asset Management reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Eagle Asset Management sold 1,117 Rigel Pharmaceuticals shares in Q4 2022, an estimated $13K.
  • Eagle Asset Management first reported a position in Rigel Pharmaceuticals in Q4 2020 and held it in 5 quarters.
  • Eagle Asset Management's Rigel Pharmaceuticals position peaked at $38K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Eagle Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.